Mangoceuticals (MGRX) traded down -4.92 % during a 24 hours period ending at 03:37 AM Central Europe on Tuesday 27th. One Mangoceuticals stock can currently be bought for about USD 0.24 on popular exchanges. Current supply of Mangoceuticals stocks is 22.2 mn. Mangoceuticals has a current market capitalization of USD 5.2 mn and approximately USD 67.4 k worth of Mangoceuticals was traded on exchanges in the last 24 hours. Since last month end, Mangoceuticals has traded -50 % down. Simple moving average of last 200 days is at USD 0.42. The highest price of past 52 weeks was recorded at USD 2.41 on 11/10/2025. 52 weeks low was at USD 0.16 on 03/20/2026.
Here is how related stocks have performed in the past 24 hours:
Cenntro (CENN) traded up 2.86 % and now trades at USD 2.64. Current market capitalisation for Cenntro is USD 5.8 mn.
Vector Science And Therapeut (PAIN.V) traded down -3.12 % and now trades at CAD 1.52. Vector Science And Therapeut has a market capitalisation of CAD 8.5 mn.
Ainos (AIMD) traded down -0.83 % and now trades at USD 0.78. Ainos has a market capitalisation of USD 6.2 mn.
Acurx (ACXP) traded down -0.44 % and now trades at USD 1.08. Current market capitalisation for Acurx is USD 6 mn.
Xwell (XWEL) traded flat 0 % and now trades at USD 0.75. Current market capitalisation for Xwell is USD 5.9 mn.
About Mangoceuticals
Mangoceuticals, Inc. is a tele-medicine service and product provider operating in the consumer staples sector with its main base located in Dallas, United States. The company offers wellness care services and products through telehealth and licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. You can find more information about their services and products on their website, www.mangorx.com , and they are listed on the Nasdaq stock exchange. Their Initial Public Offering (IPO) is scheduled for February 17, 2023.
